Canaccord Genuity Reiterates a 'Buy' on Insulet Corporation (PODD); EROS Pod On Track for Approval in Q3/12

Article Stock Quotes (1) Comments (0)

Canaccord Genuity reiterates a 'Buy' on Insulet Corporation (NASDAQ: PODD) price target of $27.00.

Analyst, William J. Plovanic, said, "We recently traveled with management from Insulet on a non-deal road show and came away with more clarity regarding 2012 catalysts, including the regulatory status of the next generation OmniPod (Eros), potential for margin improvement upon commercialization, and a longer-term view of the product pipeline."

For an analyst ratings summary and ratings history on Insulet Corporation click here. For more ratings news on Insulet Corporation click here.

Shares of Insulet Corporation closed at $20.86 yesterday, with a 52 week range of $14.00-$23.33.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Jefferies Bumps Zumiez (ZUMZ) Numbers Up, But Remains on Sidelines
• Janney Capital Boosts PT on Gap (GPS) Post Q1
• Bulls and Bears Do Battle in Aeropostale (ARO); Turnaround Intact?

Create E-mail Alert Related Categories

Analyst Comments

Related Entities

Canaccord Genuity

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?